Benfluorex as a therapeutic option for insulin resistance in HIV lipodystrophy syndrome.

about

Benfluorex as a therapeutic option for insulin resistance in HIV lipodystrophy syndrome.

Item

http://www.wikidata.org/entity/Q44873296

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Benfluorex as a therapeutic option for insulin resistance in HIV lipodystrophy syndrome.

@en

Benfluorex as a therapeutic option for insulin resistance in HIV lipodystrophy syndrome.

@nl

type

Item

label

Benfluorex as a therapeutic option for insulin resistance in HIV lipodystrophy syndrome.

@en

Benfluorex as a therapeutic option for insulin resistance in HIV lipodystrophy syndrome.

@nl

prefLabel

Benfluorex as a therapeutic option for insulin resistance in HIV lipodystrophy syndrome.

@en

Benfluorex as a therapeutic option for insulin resistance in HIV lipodystrophy syndrome.

@nl

P1476

Benfluorex as a therapeutic option for insulin resistance in HIV lipodystrophy syndrome.

@en

P2093

C Marimoutou

http://www.w3.org/2001/XMLSchema#string

D Di Stefano

http://www.w3.org/2001/XMLSchema#string

F Vion-Dury

http://www.w3.org/2001/XMLSchema#string

J A Gastaut

http://www.w3.org/2001/XMLSchema#string

K Djemli

http://www.w3.org/2001/XMLSchema#string

Ph Vague

http://www.w3.org/2001/XMLSchema#string

R Grégoire

http://www.w3.org/2001/XMLSchema#string

T Dinh

http://www.w3.org/2001/XMLSchema#string

P2860

Addition of Benfluorex to Biguanide Improves Glycemic Control in Obese Non–Insulin-Dependent Diabetes

Hyperlipidaemia in patients with HIV-1 infection receiving highly active antiretroviral therapy: epidemiology, pathogenesis, clinical course and management.

Mechanisms and strategies for insulin resistance in acquired immune deficiency syndrome.

The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation.

Hyperlactataemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factors.

Improved insulin sensitivity and body fat distribution in HIV-infected patients treated with rosiglitazone: a pilot study.

Six-month efficacy of benfluorex vs. placebo or metformin in diet-failed type 2 diabetic patients.

P304

86-90

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1310/4Y50-FGAG-PEYR-K25X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Isabelle Poizot-Martin

P577

2004-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15116284

http://www.w3.org/2001/XMLSchema#string